Last reviewed · How we verify
Molecular detection of antibiotic resistance — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Molecular detection of antibiotic resistance (Molecular detection of antibiotic resistance) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Molecular detection of antibiotic resistance TARGET | Molecular detection of antibiotic resistance | Assistance Publique - Hôpitaux de Paris | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Molecular detection of antibiotic resistance CI watch — RSS
- Molecular detection of antibiotic resistance CI watch — Atom
- Molecular detection of antibiotic resistance CI watch — JSON
- Molecular detection of antibiotic resistance alone — RSS
Cite this brief
Drug Landscape (2026). Molecular detection of antibiotic resistance — Competitive Intelligence Brief. https://druglandscape.com/ci/molecular-detection-of-antibiotic-resistance. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab